The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCirata Regulatory News (CRTA)

Share Price Information for Cirata (CRTA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.50
Bid: 50.10
Ask: 51.90
Change: 2.50 (5.00%)
Spread: 1.80 (3.593%)
Open: 50.80
High: 52.50
Low: 50.80
Prev. Close: 50.00
CRTA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

15 Feb 2024 16:27

RNS Number : 3417D
Cirata PLC
15 February 2024
 

15 February 2024

 

Cirata plc

("Cirata" or the "Company")

 

 

Director/PDMR Shareholdings

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities

 

 

Cirata plc (LSE: CRTA) provides the following notification of a transaction by persons discharging managerial responsibilities ("PDMR") relating to the vesting of shares under the 2013 Cirata plc US Equity Incentive Plan ("the Plan").

 

On 3 October 2022 Mr. Peter Lees (non-executive director) ("Mr Lees") was granted 24,560 Restricted Stock Units under the terms of the Plan ("Plan Award") all of which vested on 4 October 2023, as disclosed in the announcement of 4 October 2022.

 

On 8 December 2023, Mr. Lees sold 15,300 ordinary shares (the "Disposal") at a price of 62.25 pence per ordinary share, in part to cover the tax and national insurance liability which arose upon the vesting of the Plan Award.

 

Due to an administrative oversight, there was a delay to the notification of the Disposal. Following the Disposal, Mr Lees will be the beneficial owner of 69,260 ordinary shares, representing 0.06% of the total issued share capital of the Company.

 

The Disposal details are shown below:

 

Name of Director

Total Number of ordinary shares held 

Number of ordinary shares sold on 8 December 23

Disposal Price per ordinary share

No. Of ordinary shares remaining

Peter Lees

84,560

15,300

62.25 pence

69,260

 

 

 

 

 

For further information, please contact: 

 

Cirata

Via FTI Consulting

Stephen Kelly, Chief Executive Officer

Ijoma Maluza, Chief Financial Officer

Daniel Hayes, Investor Relations

FTI Consulting

+44 (0)20 3727 1137

Matt Dixon /Kwaku Aning / Usama Ali

Stijfel (Nomad and Joint Broker)

+44 (0)20 7710 7600

Fred Walsh / Richard Short / Tom Marsh

Liberum (Joint Broker)

+44 (0)20 3100 2000

Max Jones / Ben Cryer / Nikhil Varghese 

 

About Cirata

 

Cirata, accelerates data-driven revenue growth by automating data transfer and integration to modern cloud analytics and AI platforms without downtime or disruption. With Cirata, data leaders can leverage the power of AI and analytics across their entire enterprise data estate to freely choose analytics technologies, avoid vendor, platform, or cloud lock-in while making AI and analytics faster, cheaper, and more flexible. Cirata's portfolio of products and technology solutions make strategic adoption of modern data analytics efficient and automated. For more information about Cirata, visit www.cirata.com

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

Peter Lees

2

 

Reason for the notification

a)

 

Position/status

 

Non-Executive Director (PDMR for notification) 

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Cirata plc

b)

LEI

213800Y1A75RSC698O04

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares 10 p each

 

 

ISIN: JE00B6Y3DV84

b)

 

Nature of the transaction

 

Sale of Ordinary Shares in relation to the 2013 Cirata plc US Equity Incentive Plan

 

 

c)

 

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

62.25 pence

15,300

d)

 

Aggregated information

 

N/A

e)

 

Date of the transaction

8 December 2023

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBLGDDLDBDGSU
Date   Source Headline
29th Apr 20245:01 pmRNSFurther re: Annual Report & Notice of AGM
24th Apr 20247:00 amRNSDirectorate Change
17th Apr 20243:05 pmRNSAnnual Report & Notice of AGM
9th Apr 20247:00 amRNSQ1 FY24 Trading Update
4th Apr 20247:00 amRNSFinal Results
6th Mar 20245:19 pmRNSHolding(s) in Company
4th Mar 20242:53 pmRNSHolding(s) in Company
21st Feb 20241:27 pmRNSHolding(s) in Company
15th Feb 20244:27 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSChair appointment
9th Jan 20247:00 amRNSTrading Update
4th Jan 20243:10 pmRNSTotal Voting Rights
4th Jan 20242:41 pmRNSHolding(s) in Company
3rd Jan 20245:40 pmRNSHolding(s) in Company
2nd Jan 20249:32 amRNSNotice of Q4 FY23 Trading Update
14th Dec 20236:12 pmRNSBlock Listing Application
12th Dec 20235:32 pmRNSGrant of Share Options to PDMRs
12th Dec 20238:29 amRNSHolding(s) in Company
7th Dec 20237:00 amRNSDirector/PDMR Shareholding
6th Dec 20237:00 amRNSTotal Voting Rights
5th Dec 202310:25 amRNSHolding(s) in Company
24th Nov 20235:40 pmRNSDirector/PDMR Shareholding
23rd Nov 202310:08 amRNSHolding(s) in Company
21st Nov 20235:41 pmRNSHolding(s) in Company
21st Nov 20231:28 pmRNSHolding(s) in Company
21st Nov 20237:00 amRNSDirector/PDMR Shareholding
17th Nov 20235:54 pmRNSDirector/PDMR Shareholding
8th Nov 20231:18 pmRNSHolding(s) in Company
7th Nov 20232:39 pmRNSTotal Voting Rights
2nd Nov 20237:00 amRNSChange of Auditor
27th Oct 20235:12 pmRNSHolding(s) in Company
18th Oct 20237:00 amRNSTrading Update and Outlook
6th Oct 202312:12 pmRNSHCSC renews contract
6th Oct 202311:24 amRNSHolding(s) in Company
5th Oct 202310:39 amRNSNotice of Q3 FY23 Trading Update
5th Oct 20239:00 amRNSNatWest expands contract
5th Oct 20237:00 amRNSConfirmation of Ticker Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.